Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Stein

Showing results (151-160 of 2,502) with videos related to

Pageof 251
Sort By:
Reviews in Urology|September 21, 2006
Managing concomitant cardiac disease and erectile dysfunctionRichard A Stein
Atherosclerosis|November 12, 1998
Management of hyperlipidemia: whom and when to treat and new statin optionsE A Stein
Clinical Chemistry|April 12, 2008
After ENHANCE: is more LDL cholesterol lowering even better?Evan A Stein
The American Journal of Cardiology|March 20, 2002
Managing dyslipidemia in the high-risk patientEvan A Stein
Biochimica Et Biophysica Acta|May 12, 2000
Two problems in antisense biotechnology: in vitro delivery and the design of antisense experimentsC A Stein
Canadian Journal of Surgery. Journal Canadien De Chirurgie|May 1, 1999
Soft-tissue case 26. Gastric metastasesL A Stein
Nature Biotechnology|March 30, 1999
Keeping the biotechnology of antisense in contextC A Stein
Arteriosclerosis (Dallas, Tex.)|January 1, 1989
Treatment of familial hypercholesterolemia with drugs in childrenE A Stein
Human Pathology|September 1, 1975
Is pathology a viable discipline?A A Stein
The American Journal of Medicine|June 7, 2002
Identification and treatment of individuals at high risk of coronary heart diseaseEvan A Stein
Pageof 251

Showing results (151-160 of 2,502) with videos related to

Sort By:
Pageof 251
Reviews in Urology|September 21, 2006
Managing concomitant cardiac disease and erectile dysfunctionRichard A Stein
Atherosclerosis|November 12, 1998
Management of hyperlipidemia: whom and when to treat and new statin optionsE A Stein
Clinical Chemistry|April 12, 2008
After ENHANCE: is more LDL cholesterol lowering even better?Evan A Stein
The American Journal of Cardiology|March 20, 2002
Managing dyslipidemia in the high-risk patientEvan A Stein
Biochimica Et Biophysica Acta|May 12, 2000
Two problems in antisense biotechnology: in vitro delivery and the design of antisense experimentsC A Stein
Canadian Journal of Surgery. Journal Canadien De Chirurgie|May 1, 1999
Soft-tissue case 26. Gastric metastasesL A Stein
Nature Biotechnology|March 30, 1999
Keeping the biotechnology of antisense in contextC A Stein
Arteriosclerosis (Dallas, Tex.)|January 1, 1989
Treatment of familial hypercholesterolemia with drugs in childrenE A Stein
Human Pathology|September 1, 1975
Is pathology a viable discipline?A A Stein
The American Journal of Medicine|June 7, 2002
Identification and treatment of individuals at high risk of coronary heart diseaseEvan A Stein
Pageof 251